Introduction
CPUs were first created in the 1980s in Baltimore in the USA and have been developed to provide standardized care for patients presenting with acute non-traumatic chest pain, undiagnosed by initial clinical assessment, electrocardiogram and chest X-ray [1] . The CPU aims to provide safe and rapid evaluation of low-risk patients presenting to the emergency department with acute chest pain, to rule out an ACS and to avoid unnecessary admission to the cardiology department [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . This remains a major challenge in the USA, where there are over eight million emergency department visits annually with a suspected diagnosis of ACS. However, an ACS is confirmed in only 25% of admissions.
To the best of our knowledge, CPUs do not yet exist in France. In our country, it is recommended that patients with acute chest pain are first managed by a mobile intensive care unit, to reduce the delay to reperfusion therapy for STE-ACS [12] [13] [14] . Mobile intensive care units can also identify patients with high-risk NSTE-ACS; such cases are admitted to a CCU [15] . However, in the French FAST-MI registry, a mobile intensive care unit was the first medical contact in only 30% of cases, indicating that many patients with a subsequently proven ACS do not follow the recommended pathways. Therefore, on the basis of the evidence in the literature, the European Georges Pompidou Hospital recently incorporated a CPU within the cardiology department [16] . In this study, we examine activity in this structural CPU and describe the prevalence, demographic and clinical characteristics, and final diagnosis of patients presenting with non-traumatic chest pain. We also analyse the quality of care delivered by assessing the post-CPU clinical course in the month after admission.
Methods
This prospective study was performed in a tertiary teaching hospital in Paris. Each month, around 120-140 patients are admitted to our institution's CCU (10 beds). The monthly rate of ACSs in the CCU is around 45 cases (STE-ACS, n = 15; NSTE-ACS, n = 30). The monthly rate of admission to the emergency department is 2840 admissions, 3-5% of whom have non-traumatic chest pain.
In September 2006, a CPU was opened in the cardiology department, near the CCU. It contained five monitored beds and was open 24 h per day, 7 days a week. A cardiologist and a nurse were assigned as the CPU's full-time leaders. All the nurses had been working in the CCU previously and had attended a training course designed specifically for the management of patients with chest pain. The management protocol is summarized in Figs. 1 and 2, and was as follows: after an immediate electrocardiogram, patients were classified according to the initial diagnosis as follows: STE-ACS; NSTE-ACS; or possible ACS in cases of a normal or non-diagnostic electrocardiogram with no evident alternative diagnosis. Patients in this last diagnostic group remained in the CPU for repeat electrocardiograms and additional examinations including repeat blood tests (troponin I), chest X-ray and echocardiography. If necessary, an exercise or pharmacological stress test (electrocardiogram, echocardiography, single photon emission CT or magnetic resonance imaging) or a 64-slice CT coronary angiography were performed. Patients with a negative test were discharged. If the results were positive or inconclusive, patients were admitted to the cardiology department. On completion of the CPU protocol, patients were classified as follows (final diagnosis): STE-ACS; NSTE-ACS; non-coronary cardiac chest pain; non-cardiac chest pain; or no diagnosis (undetermined diagnosis). STE-ACS and NSTE-ACS were defined according to the guidelines of the European Society of Cardiology. Briefly, STE-ACS was defined by the association of chest pain or discomfort, persistent ST-segment elevation or (presumed) new left bundle branch block and elevated markers of myocardial necrosis (cardiac troponin I). NSTE-ACS was defined by at least two of the following criteria: chest pain or discomfort; electrocardiogram changes (ST-segment depression and/or negative T waves); and elevated markers of myocardial necrosis (cardiac troponin I).
Between September 2006 and August 2008, data were collected for each patient, including age, sex, mode of admission, cardiovascular risk factors, history of coronary artery disease, history of percutaneous coronary intervention or coronary artery bypass graft, electrocardiogram, troponin I levels and the results of echocardiography, stress test, CT or coronary angiography, if appropriate. The delay between admission and non-invasive test, length of stay and mode of discharge were also noted.
Between September 2006 and September 2007, all patients discharged with an undetermined diagnosis were evaluated prospectively at 30 days by a telephone call from a resident, to assess the incidence of missed diagnosis of ACS or coronary artery disease and the rate of readmission.
Quantitative and qualitative variables are expressed as means ± standard deviations (ranges) and percentages, respectively. Continuous variables were compared with an unpaired Student's t-test or the Mann-Whitney U test, as appropriate. Categorical variables were compared with the Chi-square test. A two-sided p-value of < 0.05 was considered to indicate statistical difference.
Results
A total of 906 patients were seen in the CPU between September 2006 and August 2008. Details of the study population characteristics are outlined in Table 1 . Two-thirds of patients were admitted to the CPU via the emergency department or the mobile intensive care unit. Twenty per cent of patients came directly from home to the CPU without passage through the emergency department or via the mobile intensive care unit; these patients came to the CPU spontaneously or via a phone call from a generalist or a cardiologist physician. One-third of patients had a previous history of coronary artery disease, including a history of revascularization by percutaneous coronary intervention or coronary artery bypass graft in 21.4% and 8.3% of patients, respectively.
The first electrocardiogram was only conclusive in 113 (13.9%) patients, with ST-segment elevation or negative T wave in 111 (12.6%) patients. These patients were immediately discharged to the catheterization laboratory or CCU when appropriate. In most cases, the electrocardiogram was normal or inconclusive (783 patients, 86.4%) and these patients remained in the CPU for further investigation by chest X-ray, echocardiography and troponin measurements. Patients presenting with a non-ischaemic cardiac aetiology (n = 123, 12.6%) or non-cardiac chest pain (n = 63, 7.0%) were discharged. Patients with a normal electrocardiogram, negative troponin tests and possible ACS without alternative diagnosis (n = 481, 53.1%) were further investigated according to risk stratification for presenting with an ACS. Patients with a very low probability of presenting with an ACS (n = 51, 5.6%) were discharged home. Patients with a low-to-moderate probability of presenting with an ACS were investigated by a stress test (n = 230, 25.4%) or 64-slice CT (n = 124, 13.7%). The stress test included electrocardiogram (n = 125, 13.9%), echocardiography (n = 29, 3.2%), single photon emission CT (n = 71, 7.8%), and magnetic resonance imaging (n = 5, 0.5%). The mean delay between admission and non-invasive test was 22 h, but was higher for patients admitted over the weekend (30 h). However, the delays were very similar for morning and afternoon admissions (21 h vs 18 h, respectively). Some patients were investigated directly by coronary angiography without stress test or CT (n = 76, 8.4%). Indications for coronary angiography are listed in Table 2 . Patients with an abnormal or inconclusive stress test or 64-slice CT were finally investigated by coronary angiography (n = 43, 4.7%; n = 13, 1.4%). In almost 40% of the cases, coronary angiography was normal ( Table 2) . Coronary angiograms were performed in 286 patients (31.6%). Overall, 114 (39.9%) patients had no significant coronary artery disease. One-vessel disease was observed in 73 (25.7%) patients, two-vessel disease in 47 (16.6%) patients and three-vessel disease in 51 (18.0%) patients. Left main coronary artery disease, spasm and coronary fistula were observed infrequently (n = 2, 2 and 1, respectively). Percutaneous coronary intervention or coronary artery bypass graft were necessary in 99 (10.9%) and 18 (2.0%) patients, respectively. Other patients with at least one stenosis >50% were treated medically.
Details of the final diagnosis are summarized in Table 3 . A final diagnosis of chest pain of undetermined origin was made frequently (51.5%). A comparison of baseline characteristics of patients admitted for chest pain related to ACS and of undetermined origin is shown in Table 4 . As expected, patients presenting with ACS were older, included a higher proportion of men, had more cardiovascular risk factors and a history of coronary artery disease or revascularization.
Overall, the percentages of patients admitted to the CCU and cardiology department were 17.1% and 19.9%, respectively, whereas 63.0% were discharged home directly. The mean length of stay in the CPU was 1.2 ± 0.8 days (0.2-2.7). In-hospital follow-up revealed that only one patient, who presented with aortic dissection, died, during surgery.
Thirty-day follow-up was performed by a resident for patients admitted to the CPU between September 2006 and October 2007 with a final diagnosis of chest pain of undetermined origin (n = 263/527, 49.9%). During this period, seven patients were lost to follow-up and 259 (97.3%) patients completed the 30-day follow-up. Among these patients, 17 (6.5%) were readmitted to the cardiology department and one patient presented with a missed diagnosis of ACS. This patient was 51-year-old and had no previous history of coronary artery disease. He was a current smoker and presented with diabetes, hypercholesterolaemia and atypical non-traumatic chest pain at rest. Electrocardiogram and troponin measurements were normal initially. Before discharge, the patient underwent a treadmill test, which was normal, but achieved only 65% of the maximal heart rate. He was readmitted to our CPU 15 days later for recurrent chest pain. The patient was investigated by single photon emission CT, which revealed a reversible anterior wall defect. Finally, a coronary angiogram was performed and showed three-vessel coronary artery disease, which was treated successfully by coronary artery bypass graft.
Discussion
This prospective, observational study aimed to determine the prevalence and clinical characteristics of patients admitted to a new CPU in France, and to assess the quality of care with regard to identification and exclusion of an ACS. A quarter of the admitted patients presented with an ACS. Non-ischaemic cardiac aetiologies and non-cardiac aetiologies were found in approximately 25% of cases. Moreover, a final diagnosis of chest pain of undetermined origin was present in 51.5% of patients. Thirty-day follow-up revealed that only one patient had subsequently confirmed coronary artery disease that required further hospitalization. These results are in accordance with those published previously in other CPUs in the USA, and indicate that a CPU is a safe, alternative means of care for patients presenting with nontraumatic chest pain.
To date, most of the data used to justify CPUs has come from studies performed in the USA. Over eight million patients visit the emergency department each year because of chest pain and a suspected diagnosis of ACS. Not all patients can be admitted to a cardiology department, as ACS is confirmed in approximately only 25% of cases. Therefore, CPUs have been created to provide standardized care in order to reduce unnecessary admission and avoid inappropriate discharge. Many prospective and retrospective studies have demonstrated clearly that CPUs improve outcomes and are cost-effective compared with routine care [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . However, the benefit of a CPU in France has not been evaluated. The results of our study suggest that a CPU in a tertiary teaching hospital may provide an alternative to routine care for the safe evaluation of these patients. We estimate that approximately one million patients present with non-traumatic chest pain each year in our country. In accordance with our observations, our study has shown that after clinical and electrocardiogram evaluation and troponin measurements, slightly fewer than 50% of patients justify additional evaluation in a CPU, where non-invasive complementary tests or a coronary angiogram can be done to rule out ACS.
In France, to our knowledge, CPUs do not yet exist. It is recommended that acute chest pains are first managed by a mobile intensive care unit, to reduce the delay to reperfusion therapy for STE-ACS [12] [13] [14] . However, patients without evidence of ischaemia, with a low-to-moderate probability of presenting with an ACS and no alternative diagnosis are frequently managed in the emergency department and cannot be admitted systematically to the CCU. Patients with normal or inconclusive electrocardiograms and normal troponin measurements are frequently discharged. In the USA, before the creation of CPUs, studies reported that approximately 2-8% of patients with an ACS were discharged home inadvertently from the emergency department. Patients with myocardial infarction or unstable angina who are discharged inadvertently are 90% and 70% more likely to die, respectively -a risk that is almost twice what would be expected if they were admitted [17] . Moreover, when they are admitted to the cardiology department, the delay in obtaining an unscheduled additional stress test or 64-slice CT is sometimes very long (more than 24 h), thus increasing the cost of the hospitalization. We therefore propose that CPUs should be associated with the plan of care for non-traumatic chest pains, particularly when the patients present spontaneously at the emergency department or are taken care of initially by a mobile intensive care unit and have no specific electrocardiogram abnormality. We believe that CPUs can offer a safe and cost-effective alternative strategy for ruling out ACSs. Furthermore, in accordance with the economic and human resources of each hospital, ''virtual or physical'' CPUs should be created to improve strategies of care, in particular to facilitate fast access to non-invasive complementary tests (stress test or 64-slice CT). Depending on the resources of each hospital, CPUs could be established in the emergency or cardiology departments, although we believe that these units should be the responsibility of a cardiologist. The formation of CPUs could create the ideal opportunity for assessing these patients, hence avoiding inappropriate discharge and unjustified and expensive hospitalizations in the cardiology department.
Our study has several limitations. First, we reported a single-centre, preliminary, observational study. Further studies using historical, retrospective, control groups and (preferably) prospective, randomized studies are mandatory for comparing the gain, in terms of diagnostic performance or speed of diagnosis, between standard care and CPUs in France. Interestingly, despite evidence to suggest that care in CPUs is more effective for such patients in USA, the percentage of emergency or cardiology departments setting up CPUs is very low in Europe. The poor development of CPUs in Europe contrasts greatly with their expansion in the USA, where more than 1500 CPUs are now available [18] . Second, the mean length of stay in our CPU was unexpectedly longer than planned compared with those reported previously in CPUs in the USA [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . In the USA, the mean length of stay varies between 15 and 17 h [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . However, CPUs in the USA are often equipped with their own treadmill test, allowing duration of stay to be decreased, particularly when patients are admitted over a weekend.
In conclusion, our study demonstrated the prevalence and clinical characteristics of patients presenting with nontraumatic chest pain to a new CPU in a tertiary teaching hospital in France, and assessed the quality of care with regard to identification and exclusion of an ACS. Further studies are warranted to evaluate the benefit and the costeffectiveness of CPUs in France.
